Canada Life
GBIO

Canada Life’s Generation Bio GBIO Stock Holding History

Canada Life’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-187
Closed -$7K – 2319
2022
Q4 		$7K Sell
187
-84
-31% -$4.41K ﹤0.01% 2338
2022
Q3 		$14K Buy
271
+21
+8% +$1.31K ﹤0.01% 2307
2022
Q2 		$16K Buy
250
+21
+9% +$1.37K ﹤0.01% 2302
2022
Q1 		$18K Buy
229
+21
+10% +$1.22K ﹤0.01% 2372
2021
Q4 		$14K Buy
208
+21
+11% +$3.67K ﹤0.01% 2421
2021
Q3 		$47K Hold
187
– – ﹤0.01% 2252
2021
Q2 		$50K Hold
187
– – ﹤0.01% 2271
2021
Q1 		$53K Buy
187
+112
+149% +$35.8K ﹤0.01% 2272
2020
Q4 		$21K Buy
+75
New +$24.1K ﹤0.01% 2528

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Canada Life's GBIO Position: Q1 2023 in Review

Canada Life sold out of Generation Bio (GBIO) in Q1 2023, closing a stake of 187 shares — an estimated $7K sold.

Canada Life first reported a position in GBIO in Q4 2020 and held it in 9 quarters. The position peaked at $53K in Q1 2021. 83 funds tracked by Wall St. Rank hold GBIO as of Q1 2023.

  • Canada Life reported no remaining Generation Bio position as of Q1 2023 after selling out during the quarter.
  • Canada Life sold 187 Generation Bio shares in Q1 2023, an estimated $7K.
  • Canada Life first reported a position in Generation Bio in Q4 2020 and held it in 9 quarters.
  • Canada Life's Generation Bio position peaked at $53K in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Generation Bio as of Q1 2023.

Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.